Posaconazole

Rank #439 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$18.0M

Total Cost

Share:

7,163

Total Claims

$18.0M

Total Cost

339

Prescribers

$2,517

Cost per Claim

438

Beneficiaries

7,327

30-Day Fills

$53K

Avg Cost/Provider

21

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$18.0M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $18.0M total

🔎 Data Overview

💰

At $2,517 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $41,155 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Posaconazole

#ProviderSpecialtyLocationClaimsCost
1Matthew BristolPodiatryNew York, NY405$1.1M
2Gundeep DhillonPulmonary DiseasePalo Alto, CA113$394K
3Kamyar AfsharPulmonary DiseaseSan Diego, CA109$318K
4Aileen GoHematology-OncologyMaywood, IL94$308K
5Sofya TokmanPulmonary DiseasePhoenix, AZ98$263K
6Adrienne TrentacostiPhysician AssistantAnn Arbor, MI98$227K
7Yazan MadanatHematology-OncologyDallas, TX52$218K
8Angela MazzocchiPhysician AssistantNew York, NY72$215K
9Gordon YungPulmonary DiseaseSan Diego, CA66$207K
10Jamie KoprivnikarHematology-OncologyHackensack, NJ57$193K
11Timothy HigginsPhysician AssistantAnn Arbor, MI74$191K
12Royce JohnsonInfectious DiseaseBakersfield, CA37$168K
13Katherine LinderHematology-OncologyHackensack, NJ49$157K
14Yasser KhaledHematologyOrlando, FL37$156K
15Kimo BachiashviliHematology-OncologyBirmingham, AL48$151K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
436Methylprednisolone (Methylprednisolone)$18.9M1,934,494
437Sacrosidase (Sucraid)$18.5M1,517
438Enasidenib Mesylate (Idhifa)$18.1M554
439Posaconazole (Posaconazole)$18.0M7,163
440Metronidazole (Metronidazole)$18.0M405,967
441Rufinamide (Rufinamide)$18.0M8,793
442Istradefylline (Nourianz)$17.8M7,061

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology